Safety and Efficacy of Fecal Microbiota Transplantation in Alleviating Symptoms of Parkinson's Disease: A Randomized, Placebo‐Controlled, Double‐Blinded Study

内科学 医学 粪便 移植 粪便细菌疗法 疾病严重程度 临床试验 不利影响 随机对照试验 梅德林 年轻人 生活质量(医疗保健) 运动活动 多中心研究
作者
Monika Figura,Łukasz Milanowski,Julia Maya Nowak,Aleksandra Antoniak,Mateusz Kopczyński,Weronika Zając,Karol Sadowski,Łukasz Hołubiuk,Weronika Walęcik-Kot,Stanisław Szlufik,Andrzej Friedman,Barbara Kaczmarczyk,Jarosław Biliński,Dariusz Koziorowski
出处
期刊:Annals of Neurology [Wiley]
卷期号:100 (1): 10-21 被引量:14
标识
DOI:10.1002/ana.78153
摘要

OBJECTIVES: Changes in the gut microbiome may be involved in the pathogenesis and progression of Parkinson's disease (PD). This randomized, placebo-controlled, double-blinded study aimed to assess the effects of fecal microbiota transplantation (FMT) on the manifestation of the motor symptoms of PD (The Movement Disorders Society - Unified Parkinson's Disease Rating Scale Part III [MDS-UPDRS III]) over a 12 month long observation and non-motor symptoms as secondary objectives: the Movement Disorders Society-Non-Motor Rating Scale; EuroQol-5 Dimension; PD Quality-of-Life Questionnaire; Montreal Cognitive Assessment (MoCA); UPDRS I, II, and IV; Gastrointestinal Dysfunction Scale for PD; modified Constipation Assessment Scale; and levodopa equivalent dose. METHODS: The patients were randomly assigned to receive either fecal microbiota (Mbiotix, Human Biome Institute) or placebo (auto-fecal microbiota, prepared from the patient's stool) in a 1:1 ratio. The fecal microbiota transplantation was performed via colonoscopy. Assessments were performed before and after 12 months for the MoCA and at 1, 3, 6, and 12 months for the other scales. Intention-to-treat analysis was performed using a multivariable mixed regression model. RESULTS: Of the 59 patients included, 28 were randomly assigned to the Mbiotix group (median age = 65 years; 15 male patients) and 31 to the placebo group (median age = 63 years; 14 male patients). No significant differences were observed in the MDS-UPDRS III "OFF" state score at 12 months between groups (1.50 points, 95% confidence interval [CI] = -4.28 to 7.28, p = 1.00), however, some non-motor symptoms improved in different study timepoints. INTERPRETATION: A single FMT does not influence motor symptoms manifestation in patients with PD but could improve non-motor functioning via gut-brain axis. Trial registration information: Clinical Trial ID NCT05204641 was submitted on November 29, 2021. The first patient was enrolled on January 4, 2022. ANN NEUROL 2026;100:10-21.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
shy发布了新的文献求助10
1秒前
倦梦还完成签到,获得积分10
1秒前
2秒前
歪比巴卜完成签到,获得积分10
2秒前
2秒前
SciGPT的应助被Verritis采纳,获得10
3秒前
4秒前
星辰大海的应助被缺粥采纳,获得10
4秒前
满意亦玉发布了新的文献求助10
4秒前
小SCI发布了新的文献求助10
4秒前
ian发布了新的文献求助10
4秒前
dalian发布了新的文献求助10
4秒前
李健的小迷弟的应助被hjy采纳,获得10
5秒前
5秒前
5秒前
5秒前
彬彬有礼完成签到 ,获得积分10
5秒前
5秒前
kikkikPCY发布了新的文献求助10
6秒前
无花果的应助被zyy采纳,获得10
6秒前
6秒前
6秒前
6秒前
十九完成签到 ,获得积分10
8秒前
8秒前
8秒前
畅快乐菱完成签到,获得积分10
8秒前
8秒前
大个的应助被嘟嘟采纳,获得10
10秒前
10秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
Xin5599发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
霁月发布了新的文献求助10
10秒前
Jasper完成签到,获得积分10
10秒前
kikkikPCY完成签到,获得积分10
11秒前
研友_VZG7GZ的应助被现代的代丝采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820